default author photo

Jonathan E. Rosenberg

Memorial Sloan Kettering Cancer Center

New York, NY 10065

United States

  • Memorial Sloan Kettering Cancer Center

SCHOLARLY PAPERS

2

DOWNLOADS

50

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Genomic Heterogeneity as a Barrier to Precision Oncology in Urothelial Cancer

Number of pages: 31 Posted: 10 Mar 2022
Timothy N. Clinton, Ziyu Chen, Hannah Wise, Andrew T. Lenis, Shweta Chavan, Mark TA Donoghue, Nima Almassi, Shawn Dason, Pavitra Rao, James Rodrigues, Naresh Vasani, Fourat Ridouani, Jonathan E. Rosenberg, Dean F. Bajorin, Min Yuen Teo, Bernard H. Bochner, Michael Berger, Irina Ostrovnaya, Eugene J. Pietzak, Gopa Iyer, Sizhi Paul Gao, Wenhuo Hu, Hikmat A. Al-Ahmadie and David B. Solit
Harvard University - Department of Surgery, Memorial Sloan Kettering Cancer Center, affiliation not provided to SSRN, Memorial Sloan Kettering Cancer Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, affiliation not provided to SSRN, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Cancer Center - Marie-Josée and Henry R. Kravis Center for Molecular Oncology
Downloads 33 (1,277,121)

Abstract:

Loading...

Bladder Cancer, Urothelial Carcinoma, ARID1A, FGFR3, cell-free DNA, metastasis, genomic heterogeneity

2.

Spatially Organized Dendritic Cell–t Cell Interactions Are Associated With Response to Cd40 Agonism in Non-muscle Invasive Bladder Cancer

Number of pages: 47 Posted: 14 Apr 2026
Juan Carlos Osorio, Lucas Blanchard, Ning Yao, Syed M. Alam, Ali Ghasemzadeh, Karissa Whiting, Venkatraman E Seshan, Andrew Mijacika, Carlo Sevilla, Juan Angulo-Lozano, Ved P. Sharma, Morgan Tomberlin, Melissa McCarter, Jessica Pfau, Jeffrey L. Wong, David Knorr, Timothy F. Donahue, Robert Smith, Eugene J. Pietzak, Benjamin D. Greenbaum, Hikmat A. Al-Ahmadie, Jonathan E. Rosenberg, Jeffrey Ravetch and Bernard H. Bochner
Rockefeller University - Laboratory of Molecular Genetics and Immunology, Rockefeller University - Laboratory of Molecular Genetics and Immunology, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Department of Epidemiology and Biostatistics, Rockefeller University - Laboratory of Molecular Genetics and Immunology, Memorial Sloan Kettering Cancer Center, affiliation not provided to SSRN, Rockefeller University - Laboratory of Molecular Genetics and Immunology, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Department of Medicine, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Rockefeller University - Laboratory of Molecular Genetics and Immunology and Memorial Sloan Kettering Cancer Center
Downloads 17 (1,481,165)

Abstract:

Loading...

CD40, Fc Receptor, non-muscle invasive bladder cancer, immune triads, tertiary lymphoid structures, dendritic cells, BCG, cancer immunotherapy, antibody, clinical trial